Alert
Close

Watch the NASCAR race on Sunday at Texas Motor Speedway. Join the Drive to End Hunger!

HIGHLIGHTS

Open

SAY THANKS TO VETERANS

Thank a Veteran with a special offer from AARP.

CONTESTS AND SWEEPS

AARP REALPAD

Introducing RealPad by AARP

AUTO BUYING PROGRAM

AARP Auto Buying Program

Download the ipad App

AARP-iPad-ePub-app

DRIVER SAFETY

Piggy bank on the road - AARP Driver Safety

Take the new AARP Smart Driver Course!

KEEP BRAIN ACTIVE!

AARP Games - Play Now!

AARP BOOKS

Planning for Long-Term Care for Dummies

Get expert advice on planning for your own or a relative’s future care needs.

Webinars

Learn From the Experts

Sign up now for an upcoming webinar or find materials from a past session.

Learning centers

Get smart strategies for managing health conditions.

 

Arthritis

Heart Disease

Diabetes

Most Popular

Viewed

Health Discovery

New Test for Prostate Cancer Proposed

Study suggests a way to refine current PSA tests

Approved in Europe, skeptics in United States

The FDA's European counterpart has already approved the test, he says. Catalona estimates that 18 percent of the 50 million American men who annually have their PSA levels tested fall into the diagnostic gray zone, so if the test is approved here, some 9 million men might be eligible to take it.

Not everyone shares Catalona's enthusiasm, however.

James L. Mohler, M.D., a urologist at the Roswell Park Cancer Institute and chair of the National Comprehensive Cancer Network's prostate cancer treatment guideline panel, says Catalona "basically improved the ability of the PSA to separate the benign from the cancer a little bit."

The study itself had some shortcomings, Mohler says.

Although Catalona "showed some differences that were interesting," the study should be repeated with more men who are studied over a longer period of time to see whether the Pro-PSA test really is more accurate.

Oliver Sartor, M.D., a urology professor and medical director of the Tulane University Cancer Center, agrees that the test is "better" at detecting who has cancer. But he cautions it's not ready for prime time, adding it may not help patients avoid biopsies. "Furthermore, the test clearly is not good enough to decide whether or not a cancer needs to be treated or not," he says.

"It moves us forward a little bit, but this isn't the answer to prostate cancer that we've all been looking for."

Michael Haederle is a freelance writer whose work has appeared in People, the New York Times and the Los Angeles Times.

You may also like: Coffee can help men who have certain prostate cancers. >>

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts

Processing

Please wait...

progress bar, please wait

Tell Us WhatYou Think

Please leave your comment below.

Discounts & Benefits

From companies that meet the high standards of service and quality set by AARP.

Grandson (8-9) whispering to grandfather, close-up

Members can save 20% on hearing aids with the AARP® Hearing Care Program provided by HearUSA.

AARP/Walgreens Wellness Bus Stops in Clarksdale, MS

Members can get exclusive points offers from Walgreens and Duane Reade.

Member Benefits

Join or renew today! AARP members receive exclusive member benefits & affect social change.

Rewards for Good

Your Points Balance:

Learn More

Earn points for completing free online activities designed to enrich your life.

Find more ways to earn points

Redeem your points to save on merchandise, travel, and more.

Find more ways to redeem points